Literature DB >> 12735999

Comparison of APF activity and epithelial growth factor levels in urine from Chinese, African-American, and white American patients with interstitial cystitis.

Chen-O u Zhang1, Ze-Liang Li, Joanna L Shoenfelt, Chui-Ze Kong, Toby C Chai, Deborah R Erickson, Kenneth M Peters, Eric S Rovner, Susan Keay.   

Abstract

OBJECTIVES: Interstitial cystitis (IC) is a chronic bladder disorder for which the etiology is unknown. We have previously shown that antiproliferative factor (APF), heparin-binding epidermal growth factor-like growth factor (HB-EGF), and epidermal growth factor (EGF) are sensitive and specific biomarkers for IC in white American patients. Because little is known about the epidemiology of this disorder, it is unclear whether these factors would also be useful biomarkers for IC in patients from different racial groups and/or geographic locations.
METHODS: Urine specimens were collected from Chinese, white American, and African-American women with IC and age and race-matched asymptomatic normal control women. APF activity was determined by (3)H-thymidine incorporation into primary normal adult human bladder epithelial cells in vitro. The HB-EGF and EGF urine levels were determined by enzyme-linked immunosorbent assay.
RESULTS: The Chinese, African-American, and white American women with IC had significantly greater urine APF activity (P <0.000001, P = 0.0008, and P <0.000001, respectively), lower urine HB-EGF levels (P <0.000001, P = 0.02, and P <0.000001, respectively), and greater urine EGF levels (P <0.000001, P = 0.002, and P <0.000001, respectively), than their matched asymptomatic controls.
CONCLUSIONS: These findings confirm the utility of APF, HB-EGF, and EGF as biomarkers for IC in patients from three different racial groups and two different countries.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12735999     DOI: 10.1016/s0090-4295(02)02597-9

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  8 in total

Review 1.  Age-Related Macular Degeneration Masquerade: A Review of Pentosan Polysulfate Maculopathy and Implications for Clinical Practice.

Authors:  Chirantan Mukhopadhyay; Timothy M Boyce; Karen M Gehrs; James C Folk; Robert F Mullins; Yi Luo; Karl Kreder; Elliott H Sohn
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2022 Mar-Apr 01

Review 2.  [Interstitial cystitis. Current aspects of diagnosis and therapy].

Authors:  A Loch; U Stein
Journal:  Urologe A       Date:  2004-09       Impact factor: 0.639

Review 3.  What's new in the diagnosis and management of painful bladder syndrome/interstitial cystitis?

Authors:  Abhishek Seth; Joel M H Teichman
Journal:  Curr Urol Rep       Date:  2008-09       Impact factor: 3.092

4.  Combination of MS protein identification and bioassay of chromatographic fractions to identify biologically active substances from complex protein sources.

Authors:  Sadao Kuromitsu; Hiroyuki Yokota; Masashi Hiramoto; Masatoshi Yuri; Masanori Naitou; Naoto Nakamura; Shigeki Kawabata; Masato Kobori; Masao Katoh; Kiyoshi Furuchi; Haruhisa Mita; Tetsuo Yamada
Journal:  Mol Cell Proteomics       Date:  2009-02-03       Impact factor: 5.911

5.  A mouse model for interstitial cystitis/painful bladder syndrome based on APF inhibition of bladder epithelial repair: a pilot study.

Authors:  Susan Keay; Samantha Leitzell; Ashley Ochrzcin; George Clements; Min Zhan; David Johnson
Journal:  BMC Urol       Date:  2012-06-08       Impact factor: 2.264

Review 6.  Urinary and Serologic Markers forInterstitial Cystitis: An Update.

Authors:  David R Wilkinson; And Deborah R Erickson
Journal:  Curr Urol Rep       Date:  2006-09       Impact factor: 2.862

7.  APF, HB-EGF, and EGF biomarkers in patients with ulcerative vs. non-ulcerative interstitial cystitis.

Authors:  Chen-Ou Zhang; Ze-Liang Li; Chui-Ze Kong
Journal:  BMC Urol       Date:  2005-04-29       Impact factor: 2.264

Review 8.  Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome with and without Hunner Lesion: A Review and Future Perspectives.

Authors:  Yoshiyuki Akiyama
Journal:  Diagnostics (Basel)       Date:  2021-11-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.